As shown by our current findings, tumor escape with multiple coinhibitory or exhaustion molecules expressed by post-BCG tissues and infiltrating CD8 T cells, which could eventually lead to the resistance to BCG treatment. The gene discussed is CD8A; the disease is neoplasm.